Medical Devices Industry Reports Atherectomy Devices Market | Page 2

REPORT DESCRIPTION
Atherectomy Devices Market – Overview
Frequent approval from different regulatory bodies to new atherectomy devices in key regions such as North
America and Europe is expected to drive growth of this market. In recent past, innovative atherectomy devices
received U.S. FDA approval and CE marking. For instance, in 2016, Medtronic Plc. received FDA clearance of
new HawkOne 6F directional atherectomy system. In 2017, Avinger Inc. received FDA 510(k) clearance for new
modified version of Pantheris Lumivascular atherectomy system. Company has modified design of previous
Pantheris Lumivascular atherectomy system in order to enhance its performance. In 2017, Cardiovascular
Systems, Inc. received approval for Diamondback 360 coronary orbital atherectomy system in U.S. Increasing
adoption for these innovative products is expected to fuel growth of the global atherectomy devices market over
the forecast period.
The Global Atherectomy Devices Market was valued at US$ 504.5 million in 2016 and is expected to witness a
CAGR of 6.2% over the forecast period (2017 – 2025).
The industry has witnessed multiple mergers & acquisitions in recent years. For instance, Boston Scientific
Corporation acquired the interventional business unit of Bayer AG in 2014. Medtronic plc acquired Covidien plc
in 2014 to strengthen its position in global atherectomy devices market.